Literature DB >> 33284652

VERTIS-CV: More Evidence That Sodium Glucose Cotransporter 2 Inhibition Brings Rapid and Sustained Heart Failure Benefit.

Faiez Zannad1, Martin R Cowie2.   

Abstract

Entities:  

Keywords:  Editorials; cardiovascular diseases; diabetes mellitus, type 2; heart failure; sodium-glucose transporter 2 inhibitors

Year:  2020        PMID： 33284652     DOI： 10.1161/CIRCULATIONAHA.120.050512

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  2 in total

Review 1.  Timely and individualized heart failure management: need for implementation into the new guidelines.

Authors:  Amr Abdin; Johann Bauersachs; Norbert Frey; Ingrid Kindermann; Andreas Link; Nikolaus Marx; Mitja Lainscak; Jonathan Slawik; Christian Werner; Jan Wintrich; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2021-05-13       Impact factor: 5.460

Review 2.  Sodium-glucose Co-transporter 2 Inhibitors: a New Path for Heart Failure Treatment.

Authors:  Jaewon Oh; Seung Hyun Lee; Chan Joo Lee; Seok Min Kang
Journal:  Korean Circ J       Date:  2021-05       Impact factor: 3.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.